Comparison of US Cancer Center Recommendations for Prostate Cancer Screening With Evidence-Based Guidelines

Elizabeth S Koh; Andrew Y J Lee; Behfar Ehdaie; Jennifer L Marti

doi:10.1001/jamainternmed.2022.0091

Comparison of US Cancer Center Recommendations for Prostate Cancer Screening With Evidence-Based Guidelines

JAMA Intern Med. 2022 May 1;182(5):555-556. doi: 10.1001/jamainternmed.2022.0091.

Authors

Elizabeth S Koh¹, Andrew Y J Lee¹, Behfar Ehdaie^{2

3}, Jennifer L Marti¹

Affiliations

¹ Department of Surgery, New York-Presbyterian/Weill Cornell Medical Center, New York, New York.
² Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Division of Health Outcomes, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Abstract

This cross-sectional study examines prostate cancer recommendations among US cancer centers to identify differences from clinical practice guidelines.

MeSH terms

Early Detection of Cancer*
Humans
Male
Mass Screening
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnosis

Substances

Prostate-Specific Antigen

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States